• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

reverse merger

door exit shut close end walk away
Biotech

Alis wants to free capital 'trapped' at struggling biotechs

Alis is proposing to buy biotechs and return most of their cash to shareholders, offering them an alternative to exits such as reverse mergers.
Nick Paul Taylor Apr 18, 2025 9:45am
Lifeline

Vincerx moves to merge with AI company to escape cash crisis

Mar 18, 2025 10:04am
Deal terminate tear up end deal scrap

Vincerx left mulling future as Oqory reverse merger falls apart

Mar 2, 2025 1:49pm
SPAC special purpose acquisition company

BridgeBio's cancer spinout backs SPAC as path to Nasdaq

Feb 28, 2025 9:25am
Graphic image of a pen signing a signature while two strangelooking business people cheer

Kadimastem gets shareholder backing for NLS merger

Jan 31, 2025 9:42am
two arrows pointing different ways

Merger for troubled liver disease biotech called off

Dec 11, 2024 12:43pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings